BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osaki M, Sakatani T, Okamoto E, Goto E, Adachi H, Ito H. Thymidine phosphorylase expression results in a decrease in apoptosis and increase in intratumoral microvessel density in human gastric carcinomas. Virchows Arch. 2000;437:31-36. [PMID: 10963377 DOI: 10.1007/s004280000205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Okamoto E, Osaki M, Kase S, Adachi H, Kaibara N, Ito H. Thymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomas. Pathol Int. 2001;51:158-164. [PMID: 11328530 DOI: 10.1046/j.1440-1827.2001.01184.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
2 Pan F, Ren JG, Zhou CW, Zhang ZY, Zhao JN, Zhou XR. Correlation of platelet-derived endothelial cell growth factor/ thymidine phosphorylase and Cox-2 expression to angiogenesis and apoptosis in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2004; 12(6): 1268-1272 [DOI: 10.11569/wcjd.v12.i6.1268] [Reference Citation Analysis]
3 Yu XQ, Deng CS, Zhu YQ, Cheng FZ. Expression and significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colorectal cancer tissue. Shijie Huaren Xiaohua Zazhi 2003; 11(8): 1197-1199 [DOI: 10.11569/wcjd.v11.i8.1197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Bijnsdorp IV, de Bruin M, Laan AC, Fukushima M, Peters GJ. The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior. Nucleosides Nucleotides Nucleic Acids 2008;27:681-91. [PMID: 18600526 DOI: 10.1080/15257770802143988] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
5 Noguchi T, Moriyama H, Wada S, Takeno S, Kimura Y, Uchida Y, Gabbert HE. High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters. Diseases of the Esophagus 2003;16:307-11. [DOI: 10.1111/j.1442-2050.2003.00352.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Kodani I, Osaki M, Shomori K, Araki K, Goto E, Ryoke K, Ito H. Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas. J Oral Pathol Med 2003;32:468-74. [PMID: 12901728 DOI: 10.1034/j.1600-0714.2003.00116.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
7 Jang JS, Lee WS, Lee JS, Kim HW, Ko GH, Ha WS. The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer. J Korean Med Sci 2007;22 Suppl:S109-14. [PMID: 17923735 DOI: 10.3346/jkms.2007.22.S.S109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Yu XQ. Preoperative administration of xeloda on the angiogenesis and expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2007; 15(1): 95-98 [DOI: 10.11569/wcjd.v15.i1.95] [Reference Citation Analysis]
9 Li W, Yue H. Thymidine phosphorylase: A potential new target for treating cardiovascular disease. Trends Cardiovasc Med 2018;28:157-71. [PMID: 29108898 DOI: 10.1016/j.tcm.2017.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
10 Tong J, Feng Y, Wang T, Luo D. Investigation of Quantitative Structure Activity Relationship of Isatin-based Oxadiazole Derivatives as Thymidine Phosphorylase Inhibitors. Chinese Journal of Analytical Chemistry 2021;49:e21046-54. [DOI: 10.1016/s1872-2040(21)60095-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhao WH, Wang SF, Ding W, Sheng JM, Ma ZM, Teng LS, Wang M, Wu FS, Luo B. Apoptosis induced by preoperative oral 5’-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol 2006; 12(9): 1356-1361 [PMID: 16552801 DOI: 10.3748/wjg.v12.i9.1356] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
12 Koide N, Nishio A, Hiraguri M, Kishimoto K, Nakamura T, Adachi W, Amano J. Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus. Dis Esophagus 2002;15:67-73. [PMID: 12060046 DOI: 10.1046/j.1442-2050.2002.00223.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
13 Wang L, Huang X, Chen Y, Jin X, Li Q, Yi TN. Prognostic value of TP/PD-ECGF and thrombocytosis in gastric carcinoma. Eur J Surg Oncol. 2012;38:568-573. [PMID: 22595739 DOI: 10.1016/j.ejso.2012.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
14 Konno S, Takebayashi Y, Aiba M, Akiyama S, Ogawa K. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Letters 2001;166:103-11. [DOI: 10.1016/s0304-3835(01)00432-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]